University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Rebecca E. Graff, ScD

Rebecca E. Graff, ScD

Assistant Professor, University of California, San Francisco, Department of Epidemiology and Biostatistics, San Francisco, CA

Cancer Center Program Memberships

Prostate Cancer

Education

University of California, Berkeley, (Berkeley, CA) BA, 05/2006, Statistics
Harvard T.H. Chan School of Public Health, (Boston, MA) ScD, 05/2014, Cancer Epidemiology
University of California, San Francisco, (San Francisco, CA) Postdoctoral, 09/2018, Genetic Cancer Epidemiology

Professional Experience

  • 2009-2014
    NIH-funded Research Trainee, Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, MA
  • 2010-2013
    Teaching Assistant, Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, MA
  • 2013-2014
    Teaching Assistant, Harvard Medical School, Boston, MA
  • 2014-2018
    NIH-funded Postdoctoral Scholar, University of California, San Francisco, Department of Epidemiology and Biostatistics, San Francisco, CA
  • 2014-2018
    Affiliated Postdoctoral Scholar, Kaiser Permanente Northern California, Division of Research, Oakland, CA
  • 2014-2018
    Small Group Facilitator, University of California, San Francisco, School of Medicine, San Francisco, CA
  • 2014-present
    Visiting Scientist, Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, MA
  • 2018-present
    Assistant Professor, University of California, San Francisco, Department of Epidemiology and Biostatistics, San Francisco, CA

Honors & Awards

  • 2006
    Phi Beta Kappa with High Distinction in General Scholarship, University of California, Berkeley
  • 2011
    Distinction in Methods on the Written Qualifying Exam, Harvard T.H. Chan School of Public
    Health, Department of Epidemiology
  • 2012
    Best of Cancer Epidemiology, Biomarkers & Prevention
  • 2012
    Invited Attendee of the Society for Epidemiologic Research Student Dissertation Workshop
  • 2013
    American Association for Cancer Research Scholar-in-Training Award
  • 2015
    Invited Attendee of the American Association for Cancer Research Integrative Molecular
    Epidemiology Workshop
  • 2016
    Winner of the NCI's Up for a Challenge competition
  • 2017
    Selected for the NCI's Epidemiology and Genomics Research Program Research Highlights

Selected Publications

  1. Ospina-Romero M, Brenowitz WD, Glymour MM, Mayeda ER, Graff RE, Witte JS, Ackley SF, Lu KP, Kobayashi LC. The Association Between Cancer and Spousal Rate of Memory Decline: A Negative Control Study to Evaluate (Unmeasured) Social Confounding of the Cancer-memory Relationship. Alzheimer Dis Assoc Disord. 2020 Jun 19.
    View on PubMed
  2. Meyers TJ, Weiner AB, Graff RE, Desai AS, Cooley LF, Catalona WJ, Hanauer SB, Wu JD, Schaeffer EM, Abdulkadir SA, Kundu SD, Witte JS. Association between inflammatory bowel disease and prostate cancer: A large-scale, prospective, population-based study. Int J Cancer. 2020 May 13.
    View on PubMed
  3. Khan S, Caldwell J, Wilson KM, Gonzalez-Feliciano AG, Peisch S, Pernar CH, Graff RE, Giovannucci EL, Mucci LA, Gerke TA, Markt SC. Baldness and Risk of Prostate Cancer in the Health Professionals Follow-up Study. Cancer Epidemiol Biomarkers Prev. 2020 Jun; 29(6):1229-1236.
    View on PubMed
  4. Monica Ospina-Romero, Willa Brenowitz, M. Maria Glymour, Elizabeth Rose Mayeda, Rebecca E. Graff, John S. Witte, Sarah Ackley, Kun Ping Lu, Lindsay C. Kobayashi. The association between cancer and spousal rate of memory decline: a negative control study to evaluate (unmeasured) social confounding of the cancer-memory relationship. medRxiv. 2020 Feb 27; 2020.02.24.20027516.
    View on PubMed
  5. Travis J. Meyers, Adam B. Weiner, Rebecca E. Graff, Anuj S. Desai, Lauren Folgosa Cooley, William J. Catalona, Stephen B. Hanauer, Jennifer D. Wu, Edward M. Schaeffer, Sarki A. Abdulkadir, Shilajit D. Kundu, John S. Witte. Association between inflammatory bowel disease and prostate cancer: A large-scale, prospective, population-based study. medRxiv. 2020 Jan 18; 2020.01.16.20017707.
    View on PubMed
  6. Kachuri L, Johansson M, Rashkin SR, Graff RE, Bossé Y, Manem V, Caporaso NE, Landi MT, Christiani DC, Vineis P, Liu G, Scelo G, Zaridze D, Shete SS, Albanes D, Aldrich MC, Tardón A, Rennert G, Chen C, Goodman GE, Doherty JA, Bickeböller H, Field JK, Davies MP, Dawn Teare M, Kiemeney LA, Bojesen SE, Haugen A, Zienolddiny S, Lam S, Le Marchand L, Cheng I, Schabath MB, Duell EJ, Andrew AS, Manjer J, Lazarus P, Arnold S, McKay JD, Emami NC, Warkentin MT, Brhane Y, Obeidat M, Martin RM, Relton C, Davey Smith G, Haycock PC, Amos CI, Brennan P, Witte JS, Hung RJ. Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility. Nat Commun. 2020 01 07; 11(1):27.
    View on PubMed
  7. Hashim D, Gonzalez-Feliciano AG, Ahearn TU, Pettersson A, Barber L, Pernar CH, Ebot EM, Isikbay M, Finn SP, Giovannucci EL, Lis RT, Loda M, Parmigiani G, Lotan T, Kantoff PW, Mucci LA, Graff RE. Family history of prostate cancer and the incidence of ERG- and phosphatase and tensin homolog-defined prostate cancer. Int J Cancer. 2020 May 15; 146(10):2694-2702.
    View on PubMed
  8. Ahearn TU, Peisch S, Pettersson A, Ebot EM, Zhou CK, Graff RE, Sinnott JA, Fazli L, Judson GL, Bismar TA, Rider JR, Gerke T, Chan JM, Fiorentino M, Flavin R, Sesso HD, Finn S, Giovannucci EL, Gleave M, Loda M, Li Z, Pollak M, Mucci LA. Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease. Carcinogenesis. 2018 12 31; 39(12):1431-1437.
    View on PubMed
  9. Pernar CH, Ebot EM, Pettersson A, Graff RE, Giunchi F, Ahearn TU, Gonzalez-Feliciano AG, Markt SC, Wilson KM, Stopsack KH, Gazeeva E, Lis RT, Parmigiani G, Rimm EB, Finn SP, Giovannucci EL, Fiorentino M, Mucci LA. A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG. Eur Urol. 2019 07; 76(1):33-40.
    View on PubMed
  10. Graff RE, Kachuri L, Witte JS. Personalized Prostate Cancer Screening Based on a Single Midlife Prostate-specific Antigen Measurement. Eur Urol. 2019 03; 75(3):408-409.
    View on PubMed
  11. Stopsack KH, Gonzalez-Feliciano AG, Peisch SF, Downer MK, Gage RA, Finn S, Lis RT, Graff RE, Pettersson A, Pernar CH, Loda M, Kantoff PW, Ahearn TU, Mucci LA. A Prospective Study of Aspirin Use and Prostate Cancer Risk by TMPRSS2:ERG Status. Cancer Epidemiol Biomarkers Prev. 2018 10; 27(10):1231-1233.
    View on PubMed
  12. Graff RE, Cho E, Preston MA, Sanchez A, Mucci LA, Wilson KM. Dietary Acrylamide Intake and Risk of Renal Cell Carcinoma in Two Large Prospective Cohorts. Cancer Epidemiol Biomarkers Prev. 2018 08; 27(8):979-982.
    View on PubMed
  13. Graff RE, Sanchez A, Tobias DK, Rodríguez D, Barrisford GW, Blute ML, Li Y, Sun Q, Preston MA, Wilson KM, Cho E. Type 2 Diabetes in Relation to the Risk of Renal Cell Carcinoma Among Men and Women in Two Large Prospective Cohort Studies. Diabetes Care. 2018 07; 41(7):1432-1437.
    View on PubMed
  14. Rebecca E. Graff, Eunyoung Cho, Mark A Preston, Alejandro Sanchez, Lorelei A. Mucci, Kathryn M. Wilson. Dietary acrylamide intake and risk of renal cell carcinoma in two large prospective cohorts. Journal of Clinical Oncology. 2018 Feb 20; 36(6_suppl):677-677.
    View on PubMed
  15. Kathryn M. Wilson, Alejandro Sanchez, Rebecca E. Graff, Sabina Signoretti, Toni K. Choueiri, David F. McDermott, Eunyoung Cho, Mark A Preston. Statin use and risk of renal cell carcinoma in three prospective cohort studies. Journal of Clinical Oncology. 2018 Feb 20; 36(6_suppl):679-679.
    View on PubMed
  16. Graff RE, Mucci LA, Hjelmborg JB. Reply. Clin Gastroenterol Hepatol. 2018 02; 16(2):298-299.
    View on PubMed
  17. Graff RE, Ahearn TU, Pettersson A, Ebot EM, Gerke T, Penney KL, Wilson KM, Markt SC, Pernar CH, Gonzalez-Feliciano AG, Song M, Lis RT, Schmidt DR, Vander Heiden MG, Fiorentino M, Giovannucci EL, Loda M, Mucci LA. Height, Obesity, and the Risk of TMPRSS2:ERG-Defined Prostate Cancer. Cancer Epidemiol Biomarkers Prev. 2018 02; 27(2):193-200.
    View on PubMed
  18. Wu YH, Graff RE, Passarelli MN, Hoffman JD, Ziv E, Hoffmann TJ, Witte JS. Identification of Pleiotropic Cancer Susceptibility Variants from Genome-Wide Association Studies Reveals Functional Characteristics. Cancer Epidemiol Biomarkers Prev. 2018 01; 27(1):75-85.
    View on PubMed
  19. Hoffman JD, Graff RE, Emami NC, Tai CG, Passarelli MN, Hu D, Huntsman S, Hadley D, Leong L, Majumdar A, Zaitlen N, Ziv E, Witte JS. Cis-eQTL-based trans-ethnic meta-analysis reveals novel genes associated with breast cancer risk. PLoS Genet. 2017 Mar; 13(3):e1006690.
    View on PubMed
  20. Hoffmann TJ, Passarelli MN, Graff RE, Emami NC, Sakoda LC, Jorgenson E, Habel LA, Shan J, Ranatunga DK, Quesenberry CP, Chao CR, Ghai NR, Aaronson D, Presti J, Nordström T, Wang Z, Berndt SI, Chanock SJ, Mosley JD, Klein RJ, Middha M, Lilja H, Melander O, Kvale MN, Kwok PY, Schaefer C, Risch N, Van Den Eeden SK, Witte JS. Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer. Nat Commun. 2017 01 31; 8:14248.
    View on PubMed

Go to UCSF Profiles, powered by CTSI